REDONDO BEACH, CA--(Marketwired - Sep 21, 2016) -, a leading financial news and information portal offering free real time public company filing alerts, recently published an article discussing Flexpoint Sensor Systems' (OTCBB: FLXT) diverse sales approach in the medical technology market.

The medical technology -- or medtech -- industry is on pace grow at a 4.1% compound annual growth rate to reach $477.5 billion by 2020, according to the marketing intelligence firm Evaluate Ltd. While giants like Medtronics Inc. and Johnson & Johnson dominate the market, smaller companies may offer the best opportunities for individual investors to realize the greatest growth rates.

Flexpoint Sensor Systems Inc. represents a unique and diversified opportunity in the medtech space. The company's patented Bend Sensor® is a flexible potentiometer with numerous uses in medical technologies. By partnering with medtech firms, the company hopes to generate stable, high-margin recurring revenue that is tied to medical device sales, making it a potentially attractive opportunity for investors.

Moving forward, the company's innovative sensors have the ability to revolutionize a number of industries, including wearables, 'quantified self', virtual reality/augmented reality (VR/AR), and Internet of Things ("IoT") and Industrial Internet of Things ("IIoT"). These broad end markets provide investors with significant diversification and exposure to a number of compelling markets that are poised for rapid and sustained growth.

To read the full article please click the following link:


Founded in 2004, provides free real time filing alerts to over 600,000 registered members and offers services to help public companies grow their audience of interested investors.


Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit:

Contact Information:
Paul Archie